Drug Type ASO |
Synonyms anti-SCN9A RNAi (EstechPharma), Olipass artificial gene therapy (EstechPharma), Olipass pain killer (EstechPharma) |
Target |
Action inhibitors |
Mechanism SCN9A gene inhibitors(Sodium channel protein type IX alpha subunit gene inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Discovery | South Korea | - |